For the Inventor, By the Inventor

Enter assignee name

Gnosis Spa

USPTO Granted Patents = 17

CIPO Patents = 2

EPO Patents = 17

Trademarks = 14

Forward Citations = 10

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Davide Bianchi (7 out of 9 patents)

Marco Valetti (6 out of 6 patents)

Ermanno Valoti (6 out of 9 patents)

4. Paola Bazza (5 out of 6 patents)

5. Daniele Giovannone (4 out of 5 patents)

6. Niccolo Miraglia (4 out of 4 patents)

7. Simona Daly (4 out of 4 patents)

8. Immacolata Busiello (3 out of 3 patents)

9. Niccolò Miraglia (2 out of 2 patents)

10. Marco Berna (2 out of 2 patents)

11. Carlo De Angelis (2 out of 3 patents)

12. Alberto Benedetti (2 out of 8 patents)

13. Antonio Trilli (2 out of 2 patents)

14. Francesca Bagatin (2 out of 2 patents)

15. Nicola Angelo Maria Volpi (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 10702482 - Slow-release solid oral compositions (2020-07-07),

2. 10632144 - Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis (2020-04-28),

3. 10563270 - Solid forms of menaquinols (2020-02-18),

4. 10471088 - Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them (2019-11-12),

5. 9908947 - Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof (2018-03-06),

6. 9834579 - Crystalline forms of s-acetyl glutathione, their preparations and uses in pharmaceutical and nutraceutical formulations (2017-12-05),

7. 9750815 - Composition comprising shellac and/or a salt thereof and sodium starch glycolate (2017-09-05),

8. 9718947 - Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof (2017-08-01),

9. 9555082 - [object Object] (2017-01-31),

10. 9365817 - [object Object] (2016-06-14),

11. 8778337 - Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of alzheimer's disease (2014-07-15),

12. 8771992 - Biotechnological production of chondroitin (2014-07-08),

13. 8664196 - Shark-like chondroitin sulphate and process for the preparation thereof (2014-03-04),

14. 8609394 - Biotechnological production of chondroitin (2013-12-17),

15. 8258115 - Stable salts of S-adenosylmethionine and process for the preparation thereof (2012-09-04),

GNOSIS SPA is a leading technology company specializing in innovative solutions for data analytics and artificial intelligence. Utilizing advanced machine learning algorithms, GNOSIS SPA helps businesses leverage the power of data to make informed decisions, optimize operations, and drive growth. With a diverse range of products and services, GNOSIS SPA caters to various industries including finance, healthcare, retail, and manufacturing. The company's commitment to delivering high-quality solutions that transform data into actionable insights has earned them a trusted reputation in the market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

17 Patents

#105 in Milan

#535 in Italy

#35,837 in the World

Gnosis Spa

Forward Citations = 10

29 inventors:

Davide Bianchi (7 out of 9 patents)

Marco Valetti (6 out of 6 patents)

Ermanno Valoti (6 out of 9 patents)

4. Paola Bazza (5 out of 6 patents)

5. Daniele Giovannone (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…